# A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity

Study · id `cardio:ct-nct01945684` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01945684](<https://clinicaltrials.gov/study/NCT01945684>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01945684

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 197 participants.

## Technical summary

Registry record NCT01945684. Randomized; triple masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 197 participants (enrolled count; ClinicalTrials.gov record NCT01945684, source copy `cardio:ctgov-nct01945684-2016-03-03`, retrieved 2026-10-26)
- Start date: 2013-09 (registry gives no type) (ClinicalTrials.gov record NCT01945684, source copy `cardio:ctgov-nct01945684-2016-03-03`, retrieved 2026-10-26)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01945684, source copy `cardio:ctgov-nct01945684-2016-03-03`, retrieved 2026-10-26)
- Completion: 2014-07 (actual) (ClinicalTrials.gov record NCT01945684, source copy `cardio:ctgov-nct01945684-2016-03-03`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01945684, source copy `cardio:ctgov-nct01945684-2016-03-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01945684-2016-03-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
- Condition: Spasticity
- Condition: Stroke
- Intervention (Drug): Botulinum toxin type A
- Lead sponsor: Daewoong Pharmaceutical Co. LTD.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Daewoong Pharmaceutical Co. LTD. (`cardio:org-daewoong-pharmaceutical-co-ltd`)

## Provenance

Content hash: 399aaae9e4aa31c55b7a2ce431e5c932d652466a1369dad13e14bc23fa484138
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
